Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ISPR
ISPR logo

ISPR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.590
Open
2.420
VWAP
2.33
Vol
39.49K
Mkt Cap
126.32M
Low
2.200
Amount
92.08K
EV/EBITDA(TTM)
--
Total Shares
57.29M
EV
124.17M
EV/OCF(TTM)
--
P/S(TTM)
1.44
Ispire Technology Inc. is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded and non-branded e-cigarettes and vaping hardware products in both the nicotine and cannabis spaces. The Company’s nicotine products are marketed under the Aspire brand name, primarily through a global distribution network. It sells its cannabis vaping hardware in the United States, Canada, South Africa, and Germany. Its cannabis products are marketed under the Ispire brand name, primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies, including multi- and single-state operators, brand owners, and co-packers. Its product portfolio includes E-Cigarette Products and Cannabis Products. The Company's open system devices are marketed under brands such as Nautilus and Zestquest and closed system products are marketed under licensed brands including BRKFST and Hidden Hills Club.
Show More

Events Timeline

(ET)
2026-02-06
07:10:00
Ispire Reports Q2 Revenue of $20.3M
select
2025-06-09 (ET)
2025-06-09
16:33:31
Ispire Technology subsidiary reaffirms full compliance with Malaysian laws
select
2025-05-22 (ET)
2025-05-22
09:02:19
Ispire Technology approved for nicotine product manufacturing in Malaysia
select
2025-05-15 (ET)
2025-05-15
16:32:52
Ispire Technology names Jay Yu as CFO, reduces workforce
select
2025-05-01 (ET)
2025-05-01
08:39:31
Ispire Technology files application with FDA for age-verification component
select
2025-02-10 (ET)
2025-02-10
06:14:43
Ispire Technology reports Q2 EPS (14c) vs. (7c) last year
select
2024-11-18 (ET)
2024-11-18
07:35:17
Ispire Technology, IKE Tech announce pre-PMTA submission meeting with FDA
select
2024-11-11 (ET)
2024-11-11
06:03:29
Ispire Technology reports Q1 EPS (10c) vs. (2c) last year
select

News

NASDAQ.COM
2.0
02-24NASDAQ.COM
Hospital and Medical Practitioners Stocks Decline
  • Market Underperformance: On Tuesday, hospital and medical practitioners' stocks collectively fell by approximately 1.2%, indicating a decline in market confidence in the sector, which could negatively impact long-term investor expectations.
  • AdaptHealth Leads Decline: AdaptHealth's stock plummeted by about 13.6%, making it the worst performer in the industry, suggesting potential operational or financial challenges that could affect its market share.
  • Centene Pressured: Centene's stock decreased by approximately 3.5%, and although the drop is smaller, it still reflects market concerns regarding its future growth, potentially prompting investors to reassess their investment strategies.
  • Industry Trend Warning: The overall decline in the healthcare sector may signal broader economic issues, prompting investors to monitor relevant policy changes and market dynamics to adjust their portfolios accordingly.
seekingalpha
9.5
02-06seekingalpha
Ispire Technology Q2 Earnings Report Analysis
  • Poor Earnings Performance: Ispire Technology reported a Q2 GAAP EPS of -$0.12, indicating ongoing challenges in profitability, which reflects the increasing market pressures and competition the company faces.
  • Significant Revenue Decline: The reported revenue of $20.29 million represents a 51.5% year-over-year decrease, missing expectations by $12.51 million, a situation that could undermine investor confidence and negatively impact future financing capabilities.
  • Cash Flow Position: As of December 31, 2025, Ispire held $17.6 million in cash and $3.5 million in working capital; while the cash reserves are adequate, ongoing losses may limit future operational flexibility and growth potential.
  • Market Reaction Outlook: Given the poor financial performance, the market is expected to adopt a cautious stance towards Ispire's future prospects, potentially leading to increased stock price volatility, prompting investors to closely monitor the company's subsequent strategic adjustments and market responses.
PRnewswire
9.5
02-06PRnewswire
Ispire Technology Reports Key Financial Highlights for Q2 2026
  • Significant Accounts Receivable Reduction: As of December 31, 2025, Ispire's net accounts receivable decreased by 19.5% to $37.9 million from $47.0 million at the end of fiscal 2025, demonstrating the company's success in managing high-quality customers and enhancing financial flexibility.
  • Revenue and Gross Profit Decline: The revenue for Q2 2026 was $20.3 million, a substantial drop from $41.8 million in the same period last year, primarily due to a strategic shift away from lower-quality customers, resulting in decreased overall product sales and a gross margin decline from 18.5% to 17.1%.
  • Operating Expenses Significantly Lowered: The company reported operating expenses of $10.3 million in Q2, down from $15.1 million, highlighting the effectiveness of its cost control measures, which lay a solid foundation for future profitability.
  • Strong Cash Position: Ispire held $17.6 million in cash as of December 31, 2025, indicating financial stability in ongoing investments and operations, thereby supporting future growth initiatives.
Newsfilter
9.5
02-06Newsfilter
Ispire Technology Reports Q2 Fiscal 2026 Financial Results
  • Revenue Decline: Ispire reported revenue of $20.3 million for Q2 FY2026, a significant 51.5% decrease from $41.8 million in Q2 FY2025, reflecting the company's strategic shift away from lower-quality customers, resulting in reduced overall product sales.
  • Gross Profit and Margin: The gross profit for the quarter was $3.5 million with a gross margin of 17.1%, down from $7.7 million and 18.5% in the prior year, primarily due to a change in product mix with fewer high-margin products sold.
  • Operating Expense Control: Total operating expenses decreased from $15.1 million in Q2 FY2025 to $10.3 million in Q2 FY2026, highlighting significant progress in cost control initiatives that enhance financial flexibility.
  • Accounts Receivable Reduction: As of December 31, 2025, Ispire's net accounts receivable decreased by 19.5% to $37.9 million from $47.0 million as of June 30, 2025, indicating the company's ongoing focus on improving customer quality.
PRnewswire
8.0
02-04PRnewswire
FDA Recognizes IKE Tech as Key Stakeholder in ENDS Regulation
  • FDA Roundtable Invitation: IKE Tech's invitation to the FDA's roundtable discussion for small ENDS manufacturers underscores its importance in the PMTA submission process, with participation limited to 30 companies, highlighting IKE Tech's critical role in the regulatory framework.
  • Technological Innovation Showcase: IKE is developing a blockchain and Bluetooth-based age verification technology designed to ensure legal-age access at the point of use, positioning this innovation as a potential game-changer for future compliance standards in the industry.
  • Strategic Investment Significance: Ispire's investment in IKE Tech places it at the center of regulatory dialogue, emphasizing the critical role of technology in enhancing compliance and protecting youth, thereby helping the company establish a competitive edge in the market.
  • Industry Feedback Opportunity: The FDA roundtable provides manufacturers with a platform to share their PMTA submission experiences, which is expected to inform future FDA guidelines and improvements to the PMTA review process, further driving compliance and innovation in the industry.
Newsfilter
8.0
02-04Newsfilter
Ispire Technology Invited to FDA Roundtable on ENDS Regulation
  • FDA Recognition: Ispire's joint venture, IKE Tech, has been invited to participate in the FDA's roundtable discussion, underscoring its critical role in the regulation of electronic nicotine delivery systems (ENDS) and enhancing the company's influence in the industry.
  • Strategic Technological Innovation: IKE Tech is developing a blockchain-enabled, Bluetooth-based age verification system aimed at ensuring legal-age access, positioning this innovation as a potential cornerstone for future regulatory compliance and enhancing the company's competitive edge in the market.
  • Opportunity for Industry Dialogue: The roundtable will gather 30 small ENDS manufacturers, and Ispire's participation not only allows for the sharing of experiences but also influences future FDA guidance, promoting the elevation of industry standards.
  • Long-term Commitment and Investment: Ispire's strategic investment in IKE Tech demonstrates its long-term commitment to safety-focused innovation and regulatory readiness, aiming to leverage technological advancements to protect youth and support the development of lawful market pathways.
Wall Street analysts forecast ISPR stock price to rise
1 Analyst Rating
Wall Street analysts forecast ISPR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
6.50
Averages
6.50
High
6.50
Current: 0.000
sliders
Low
6.50
Averages
6.50
High
6.50
Roth Capital
Buy
downgrade
$9
AI Analysis
2025-05-15
Reason
Roth Capital
Price Target
$9
AI Analysis
2025-05-15
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Ispire Technology to $7.50 from $9 and keeps a Buy rating on the shares. The company's Q2 results were "tempered" as shipment timing on its U.K. supply agreement is being pushed into fiscal Q4 and given that Chinese New Year seasonality and tariffs are also impacting order timing, the analyst tells investors in a research note. An FDA decision in the coming months should provide greater future visibility around licensing opportunities, the firm adds.
Roth MKM
Nick Anderson
Strong Buy
Reiterates
$9
2025-03-20
Reason
Roth MKM
Nick Anderson
Price Target
$9
2025-03-20
Reiterates
Strong Buy
Reason

Valuation Metrics

The current forward P/E ratio for Ispire Technology Inc (ISPR.O) is -49.74, compared to its 5-year average forward P/E of -9.93. For a more detailed relative valuation and DCF analysis to assess Ispire Technology Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-9.93
Current PE
-49.74
Overvalued PE
188.41
Undervalued PE
-208.27

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-24.81
Current EV/EBITDA
23.50
Overvalued EV/EBITDA
6.37
Undervalued EV/EBITDA
-56.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.60
Current PS
1.07
Overvalued PS
2.54
Undervalued PS
0.65

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

any other good options to consider
Intellectia · 41 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Analyst Consensus: Moderate Buy, Strong BuyRelative Vol: >= 1.50Month Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
SES logo
SES
SES AI Corp
861.57M
LAES logo
LAES
Sealsq Corp
830.10M
GAU logo
GAU
Galiano Gold Inc
745.60M
UROY logo
UROY
Uranium Royalty Corp
655.79M
EU logo
EU
enCore Energy Corp
610.54M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
penny stocks to buy tomorrow
Intellectia · 20 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Relative Vol: >= 1.50Earnings Surprise: EpsBeatWeek Price Change Pct: >= $3.00
Ticker
Name
Market Cap$
top bottom
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
INN logo
INN
Summit Hotel Properties Inc
526.61M
ACTG logo
ACTG
Acacia Research Corp
385.84M
AUNA logo
AUNA
Auna SA
364.88M
GLDG logo
GLDG
GoldMining Inc
344.04M
TYGO logo
TYGO
Tigo Energy Inc
243.42M
Show bullish stocks value between $1 to $4
Intellectia · 12 candidates
Price: $1.00 - $4.00Relative Vol: >= 1.50Rsi 14: 65 - 70Moving Average Relationship: PriceAboveMA20Month Price Change Pct: >= $10.00
Ticker
Name
Market Cap$
top bottom
BBD logo
BBD
Banco Bradesco SA
39.45B
EU logo
EU
enCore Energy Corp
610.54M
TRUE logo
TRUE
TrueCar Inc
225.91M
SRG logo
SRG
Seritage Growth Properties
215.16M
ISPR logo
ISPR
Ispire Technology Inc
191.35M
ONCY logo
ONCY
Oncolytics Biotech Inc
125.90M

Whales Holding ISPR

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ispire Technology Inc (ISPR) stock price today?

The current price of ISPR is 2.205 USD — it has decreased -10

What is Ispire Technology Inc (ISPR)'s business?

Ispire Technology Inc. is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded and non-branded e-cigarettes and vaping hardware products in both the nicotine and cannabis spaces. The Company’s nicotine products are marketed under the Aspire brand name, primarily through a global distribution network. It sells its cannabis vaping hardware in the United States, Canada, South Africa, and Germany. Its cannabis products are marketed under the Ispire brand name, primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies, including multi- and single-state operators, brand owners, and co-packers. Its product portfolio includes E-Cigarette Products and Cannabis Products. The Company's open system devices are marketed under brands such as Nautilus and Zestquest and closed system products are marketed under licensed brands including BRKFST and Hidden Hills Club.

What is the price predicton of ISPR Stock?

Wall Street analysts forecast ISPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPR is6.50 USD with a low forecast of 6.50 USD and a high forecast of 6.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ispire Technology Inc (ISPR)'s revenue for the last quarter?

Ispire Technology Inc revenue for the last quarter amounts to 20.29M USD, decreased -51.50

What is Ispire Technology Inc (ISPR)'s earnings per share (EPS) for the last quarter?

Ispire Technology Inc. EPS for the last quarter amounts to -0.12 USD, decreased -14.29

How many employees does Ispire Technology Inc (ISPR). have?

Ispire Technology Inc (ISPR) has 81 emplpoyees as of March 11 2026.

What is Ispire Technology Inc (ISPR) market cap?

Today ISPR has the market capitalization of 126.32M USD.